Order Article Reprints

Mizutani A, Kobayashi M, Ohuchi M, Sasaki K, Muranaka Y, Torikai Y, Fukakusa S, Suzuki C, Nishii R, Haruta S, et al. Indirect SPECT Imaging Evaluation for Possible Nose-to-Brain Drug Delivery Using a Compound with Poor Blood–Brain Barrier Permeability in Mice. Pharmaceutics. 2022; 14(5):1026. https://doi.org/10.3390/pharmaceutics14051026

Mizutani, Asuka, Masato Kobayashi, Makoto Ohuchi, Keita Sasaki, Yuka Muranaka, Yusuke Torikai, Shota Fukakusa, Chie Suzuki, Ryuichi Nishii, Shunji Haruta, and et al. 2022. "Indirect SPECT Imaging Evaluation for Possible Nose-to-Brain Drug Delivery Using a Compound with Poor Blood–Brain Barrier Permeability in Mice" Pharmaceutics 14, no. 5: 1026. https://doi.org/10.3390/pharmaceutics14051026

Mizutani, A., Kobayashi, M., Ohuchi, M., Sasaki, K., Muranaka, Y., Torikai, Y., Fukakusa, S., Suzuki, C., Nishii, R., Haruta, S., Magata, Y., & Kawai, K. (2022). Indirect SPECT Imaging Evaluation for Possible Nose-to-Brain Drug Delivery Using a Compound with Poor Blood–Brain Barrier Permeability in Mice. Pharmaceutics, 14(5), 1026. https://doi.org/10.3390/pharmaceutics14051026